CJ Cheiljedang Corporation Overview
CJ CheilJedang is South Korea's largest food company. It is the flagship operating unit of CJ Group, and through a 40.16% stake it consolidates CJ Logistics, Korea's largest logistics company. Its core is a branded processed-food franchise built around bibigo, Hetbahn, Beksul and Dasida. Since the 2019 acquisition of US frozen-food maker Schwan's, that franchise has become a global K-food platform. In FY2025 overseas food sales (KRW 5.92tn) exceeded domestic food sales for the first time. The second pillar is a scale biotechnology business: fermentation-derived amino acids (lysine, tryptophan, valine, arginine and others), nucleotides and specialty ingredients. The company has historically been the world's largest amino acid producer. The company is now in its most significant restructuring since the 2007 spin-off. It divested CJ Feed&Care, abandoned a planned sale of the bio business, and on 1 July 2026 reorganized into three divisions (Lifestyle Food, Technology Materials, Core Materials). It is also contending with record antitrust fines, compressed bio margins and elevated leverage.
What the company does
CJ CheilJedang operates three business families, plus one consolidated subsidiary group:
-
Food (now "Lifestyle Food")
-
Branded processed foods: frozen dumplings (mandu), instant/processed rice, kimchi, seaweed snacks, sauces and pastes, chicken, frozen pizza, desserts, Asian appetizers, and beverages including fruit vinegar.
-
Domestic "food ingredients" businesses: sugar, flour, edible oils, starch sweeteners and premixes. Under the July 2026 reorganization these sit in Core Materials.
-
Operates globally. North America runs through CJ Foods America / CJ Schwan's, and there are platforms in Japan, China, Vietnam, Europe and Oceania.
-
-
Bio (now split into "Technology Materials" and "Core Materials")
-
Fermentation-based "green bio" products.
-
Feed-grade amino acids: lysine, threonine, tryptophan, methionine, valine, arginine, isoleucine, histidine.
-
Food-grade flavour enhancers: nucleotides (IMP/GMP) and the natural seasoning material TasteNrich.
-
New materials: PHA biodegradable plastic and allulose.
-
Per Korean press (KED, Feb 2025), amino acids account for about 90% of bio sales.
-
-
Red bio / health (non-core, small)
-
CJ Bioscience (microbiome therapeutics, launched January 2022).
-
Batavia Biosciences (Dutch cell and gene therapy CDMO; 75.8% stake acquired in 2021).
-
CJ Wellcare (health functional foods).
-
-
CJ Logistics (consolidated, 40.16% owned)
-
Korea's largest parcel, contract logistics and global forwarding company.
-
By revenue it is the largest consolidated segment: about 43% of Q2 2026 consolidated sales, versus 39% food and 18% bio (Butler.works segment split).
-
Business and revenue model
| Dimension | Characterization |
|---|---|
| Product vs. service mix | Predominantly product sales (processed foods, food ingredients, amino acids). Service revenue comes almost entirely from CJ Logistics. Subscription and licensing revenue is immaterial, although the company licensed lysine strain technology to a Chinese producer in February 2026 (CJ newsroom) |
| Value-chain position | Vertically integrated from commodity processing (raw sugar, wheat, corn, soybean) through fermentation and food manufacturing to branded consumer goods. Logistics adds downstream distribution capability |
| Customer types | B2C through grocery, convenience, e-commerce (including Coupang, after a 2022–2024 supply dispute was settled) and club stores. B2B covers food service, food manufacturers (sugar, flour, starch syrups), feed compounders and integrators (amino acids), and CPG companies (TasteNrich, nucleotides, PHA) |
| End-markets | Packaged food (Korea, US, Japan, China, Europe, Oceania); animal nutrition (global swine and poultry); food ingredients; bioplastics; healthcare (marginal) |
Company self-description (paraphrased)
Recent IR and recruitment materials describe CJ CheilJedang as a global company that uses distinctive technology and core-materials competitiveness to lead a healthy, enjoyable "lifestyle food" culture and to provide solutions (CJ CheilJedang H2 2026 recruitment notice, September 2026). The FY2025 Sustainability Report, signed by CEO Yoon Seok-hwan, frames the year as one of strategic portfolio reorganization.
Independent characterization
CJ CheilJedang is best understood as three businesses with very different economics sharing one balance sheet:
-
A structurally growing but low-margin global branded-food franchise. FY2025 food operating margin was about 4.6%. It is driven by overseas K-food demand and is held back by a mature, price-regulated domestic market.
-
A highly cyclical, capital-intensive commodity fermentation business. Bio OP fell 36.7% in FY2025 and to KRW 5.5bn in Q1 2026. Its earnings swing with Chinese capacity additions, grain costs and feed-sector demand.
A logistics subsidiary: It inflates consolidated revenue but contributes only 40.16% of its earnings to shareholders.
The company's own strategy now treats branded K-food as the core and the remaining materials businesses as candidates for selective investment, harvest or exit.
Strategy
Stated strategic themes (paraphrased from FY2025–2026 disclosures)
-
Maximize overseas food growth. Expand into new global markets ("K-food new territory expansion") with GSPs such as dumplings, processed rice and Hetbahn (FY2025 results statement; Q2 2026 statement).
-
Restructure the bio business and create new demand to restore profitability (FY2025 results statement).
-
Management efficiency. Cut manufacturing and fixed costs and focus on high-margin products (Q2 2026 statement).
-
Rebalance the portfolio around three divisions. Divest low-growth, low-margin "marginal businesses" and redeploy resources to future growth (July 2026 reorganization statement).
-
Become a "global lifestyle leader" (CEO Yoon, as reported in July 2026 coverage).
Initiatives register (last 24 months)
| Date | Initiative | Detail | Status |
|---|---|---|---|
| Nov 2024 | Hungary plant | About KRW 100bn; bibigo dumplings for Europe; chicken line later | Opening scheduled 2H 2026 (n/v whether started) |
| Nov 2024 | Sioux Falls plant | More than KRW 700bn; dumplings and egg rolls | Completion 2027 |
| 2,025 | Japan Chiba plant | About KRW 100bn | Operating since Sep 2025 |
| Nov 2024–Apr 2025 | Bio business sale (about KRW 6tn) | Morgan Stanley process | Cancelled 30 Apr 2025 |
| Oct 2025–Mar 2026 | CJ Feed&Care divestment | EV about KRW 1tn to Royal De Heus | Closed |
| Feb 2026 | Lysine strain patent collaboration with Chinese producer Xinghuipin | Technology monetization | Announced |
| Feb 2026 | Cost-linked pricing system for sugar; withdrawal from the Korea Sugar Manufacturers Association; staff barred from contact with competitors | Antitrust remediation | Implemented (company statements via Bizhankook) |
| Feb 2026 | Price cuts on starch sugar and flour | Response to government price-stabilization push | Implemented |
| Mar 2026 | Future Innovation Office under the CEO | Structural reform | Established |
| Mar 2026 | PHA supply to Conspec (India) | Bioplastics commercialization | Announced |
| Mar 2026 | Automated kimbap production facility | Manufacturing technology | Built |
| Jul 2026 | Three-division reorganization | Lifestyle Food / Technology Materials / Core Materials | Effective 1 Jul 2026 |
| Jul 2026 | Non-core asset monetization | About KRW 230bn of plants; sale-leaseback | Under review |
| Jul 2026 | Starch-sweetener divestment | About KRW 300bn; carve-out sale to financial investors | Under review ("nothing finalized") |
| Jul–Sep 2026 | Premium spirits (jari) | US fine-dining launch | Launched |
| Ongoing | Renewable energy (solar, long-term PPAs); Net Zero & Zero Waste 2050 | ESG | See Section 20 |
Guidance and targets
| Item | Guidance | Source |
|---|---|---|
| FY2025 (issued Feb 2025) | Low-single-digit consolidated sales growth | Hanwha Securities, Feb 2025 |
| Q4 2025 (issued Nov 2025) | Sales up low single digits YoY | Kiwoom, Nov 2025 |
| Q3 2026 (issued Aug 2026) | Consolidated sales up low double digits YoY; operating margin in the mid-to-high 4% range. Bio profitability to recover YoY but may dip QoQ on oil prices | Quartr Q2 2026 summary |
| Medium-term financial targets (3–5 years) | n/d. No quantified medium-term plan was found in public sources reviewed | — |
| Shareholder return | Quarterly dividends since 2022. The 2022 policy was a payout of at least 20% of separate net income excluding one-offs. KRW 1,500 quarterly payments in 2025–2026 | Dealsite, May 2023; dividend calendars |
Products & Services
Pricing is not publicly disclosed for any product line. CJ sells at list/negotiated wholesale prices to retail and B2B customers. The KFTC has ordered CJ to report sugar price changes and has issued price-reset orders in flour.
Lifestyle Food — global strategic products (GSP)
| Brand / product | Description | Target customer | Launch / latest | Notes and flagships |
|---|---|---|---|---|
| bibigo Mandu (dumplings) | Frozen Korean dumplings in multiple formats, including mini wontons and steamed dumplings; whole-shrimp dumplings are a domestic "mega-hit" being exported | Retail (US, Europe, Japan, China, Oceania), food service | bibigo brand launched 2010 (n/v); Japan Chiba plant from Sep 2025; Hungary plant scheduled 2H 2026 | 42% share of the US B2C dumpling market (CJ press release, Nov 2024). US dumpling sales +31% in Q2 2026 (Hanwha/StockHub) |
| Hetbahn / processed rice / frozen rice | Shelf-stable cooked rice (Hetbahn) and frozen fried rice; ambient processed rice is a key US growth line | Korean and global retail | Hetbahn 1996 (n/v this cycle) | North American ambient processed rice +39% in Q1 2025 (Dealsite) |
| bibigo Chicken | Korean fried chicken (e.g., "Sobaba Chicken") | Retail | Hungary chicken line planned as a phase-2 expansion | — |
| bibigo Kimchi | Packaged kimchi; Australian OEM production | Retail | — | GSP category |
| bibigo Gim (seaweed) | Seaweed snacks | Retail | — | GSP category |
| K-Sauce / Gochujang (Haechandle), kimchi cooking sauce | Fermented pastes and all-purpose sauces | Retail, food service | All-purpose kimchi cooking sauce launched for the global market (CJ Newsroom, Sep 2025) | — |
| Noodles / kimchi ramen | bibigo noodle and ramen products | Retail | — | Sampled at KCON LA 2026 |
| Frozen kimbap | Seaweed rice rolls; first overseas launch in Japan (2023); 2.5m units sold in Japan by 2024 | Retail | Industry-first automated kimbap production facility (CJ press release, 25 Mar 2026) | — |
| Mi-cho | Fruit vinegar drink | Retail (Korea, Japan) | — | Japan sales +37% in Q2 2025 driven by Mi-cho and dumplings |
| jari | Premium Korean distilled spirit (three SKUs) | Korean fine-dining channel in the US | Unveiled Jul 2026; New York launch Sep 2026 | New category entry; positioned as "lifestyle" extension |
| Cuisine K | Korean culinary brand/education platform (cooking classes in LA and New York) | Consumers, brand building | Apr 2026 | Marketing platform |
Lifestyle Food — North America (CJ Foods America / CJ Schwan's)
| Brand | Category | Notes |
|---|---|---|
| Red Baron, Tony's, Freschetta | Frozen pizza | Pizza +10% in Q1 2025 North America (Dealsite). Pizza weakness flagged in 2Q26 previews (DS Securities) |
| Mrs. Smith's, Edwards | Frozen pies and desserts | A US pie plant was idled by a tornado in Q1 2025, raising fixed-cost burden (Dealsite, May 2025) |
| Pagoda, Minh, Kahiki | Asian-style egg rolls, appetizers, entrées | CJ Schwan's describes itself as the leading US producer of Asian-style snacks and appetizers (CJ press release, Nov 2024) |
| Food service (Schwan's Food Service) | Pizza, dessert, Asian appetizers for schools and food service | Sioux Falls plant (2027) to make steamed dumplings and egg rolls for food service |
Domestic consumer brands (Korea)
| Brand | Category | Notes |
|---|---|---|
| Beksul | Sugar, flour, cooking oil, premixes, syrups | Consumer and B2B ingredient brand |
| Dasida | Beef-stock and seasoning powders | Heritage flavour brand (1975, n/v) |
| Spam (Korea) | Canned luncheon meat under licence | Holiday gift sets drive Q1/Q4 seasonality |
| Gourmet | Frozen HMR | — |
| CJ Wellcare (subsidiary) | Health functional foods: Bio-Core 50bn probiotics, Jeonripso prostate supplement (Apr 2026), Innerb PDRN (oral), health gummies (7 SKUs, Apr 2026) | CJ press releases, Mar–Apr 2026 |
Core Materials (from Jul 2026)
| Product | Description | Notes |
|---|---|---|
| Lysine | Feed-grade essential amino acid for swine/poultry; CJ's largest-volume bio product | Exposed to Chinese capacity; the EU anti-dumping rate on Chinese lysine was set lower than expected (Hana, Sep 2025) |
| Tryptophan | High-margin feed amino acid | Intensifying competition cut Q1–Q2 2026 profitability (Herald Corp, Aug 2026) |
| Threonine, methionine | Feed amino acids; methionine produced in Malaysia (n/v this cycle) | Strong methionine sales cited in 2Q26 preview (DS Securities) |
| Sugar | Refined sugar (Beksul) | Subject to KFTC fine and price-reporting order |
| Flour | Milled wheat flour | Top-3 Korean miller; subject to KFTC fine |
| Edible oils | Soybean and other oils (Incheon 3 plant) | Incheon 3 flagged as a non-core asset for sale-leaseback |
| Starch sweeteners | Corn starch, corn syrup, glucose, fructose for beverage, confectionery and bakery customers | Sale under review; CJ is 4th in the Korean market with a low-10% share |
| Oligosaccharides, premixes | Processed ingredients | — |
| Allulose | Rare low-calorie sugar | "New material" within Core Materials |
| CJ Selecta (66%) | Brazilian soy-protein concentrate for feed, chemical and pharma uses | Sale cancelled in April 2025; retained |
Technology Materials (from Jul 2026)
| Product | Description | Notes |
|---|---|---|
| Nucleotides (IMP/GMP) | Flavour enhancers for food manufacturers | Competition intensified in 2025 |
| TasteNrich (TnR) | Natural fermentation-based seasoning/flavour material for premium taste and sodium reduction | Q3 2024 sales +35%; new customers in 2025, though margin was diluted by higher production cost |
| Specialty amino acids | Valine, arginine, isoleucine, histidine, citrulline, cysteine | Specialty share of bio sales reached a record 21% in FY2024 and 22% in Q3 2024 (Dealsite; Youth Daily) |
| PHA (polyhydroxyalkanoate) | Marine-degradable bioplastic, including amorphous PHA grades | Supply deal with Indian compounder Conspec (CJ press release, 30 Mar 2026); commercialized across several industries per FY2025 SR |
Red bio (non-core)
| Entity | Activity | Status |
|---|---|---|
| CJ Bioscience | Microbiome-based drug discovery and analysis platform; pipeline n/v this cycle; skin–gut research MOU with a dermatology clinic (Mar 2026) | Small; strategic fit questioned under the new structure |
| Batavia Biosciences | Viral-vector and vaccine process development and GMP manufacturing (Leiden, Netherlands) | Korean press reported in April 2026 that Batavia was struggling to normalize operations (CB Insights news digest) |
Financial Narrative
Income statement — consolidated (incl. CJ Logistics), as originally reported
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Key products |
|---|---|---|
Food | Domestic processed food, domestic food ingredients (sugar, flour, oil, starch syrups), overseas food (CJ Foods America/Schwan's, Japan, China, Vietnam, Europe, Oceania) | bibigo, Hetbahn, Beksul, Dasida, Gourmet, Spam (Korea), Red Baron, Tony's, Mrs. Smith's |
Bio | Feed amino acids, food-grade nucleotides, TasteNrich, specialty amino acids, CJ Selecta soy protein, PHA, allulose | Lysine, threonine, tryptophan, methionine, valine, arginine, isoleucine, histidine, citrulline |
CJ Feed&Care (until divestment) | Compound feed, livestock and fresh meat in Korea, Vietnam, Indonesia, Philippines, Cambodia, China and Myanmar | Swine/poultry feed; livestock |
CJ Logistics (40.16%) | Parcel (O-NE brand), contract logistics, global forwarding | — |
Division Overview
| Division | Scope | Head | Source |
|---|---|---|---|
Lifestyle Food | Global K-food centre: global strategic products (GSP) such as bibigo dumplings, chicken, processed rice, sauces and kimchi, plus domestic consumer foods | Gregory Yep (food division head since 2025; more than 30 years in global food/nutrition R&D and innovation) | Herald Corp, 1 Jul 2026 |
Technology Materials | High-value R&D-led materials: nucleotides, TasteNrich, PHA biodegradable plastic; solutions-based B2B | CEO Yoon Seok-hwan (concurrent) | Nocut News, Jul 2026 |
Core Materials | Feed amino acids (lysine, tryptophan), general ingredients (sugar, flour, edible oil), processed materials (oligosaccharides, premixes), new materials (allulose) | Kim Chan-ho, Head of Strategic Support (concurrent) | Herald Corp; Edaily, Jul 2026 |
CJ Logistics | Unchanged; consolidated subsidiary | Shin Young-soo (CJ Logistics CEO) | CJ Newsroom |
Segment revenue (KRW Bn)
| Segment revenue (KRW Bn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Food (total) | 11,263 | 11,353 | 11,522 |
of which Overseas food | 5,388 | 5,581 | 5,925 |
of which Domestic food | 5,877 | 5,772 | 5,597 |
Bio | 4,135 | 4,210 | 3,959 |
CJ Feed&Care | 2,493 | 2,309 | 0 |
Total ex-logistics | 17,891 | 17,871 | 17,755 |
Revenue by Segment
| Segment OP (KRW Bn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Food | 655 | 620 | 526 |
Bio | 251 | 338 | 203 |
CJ Feed&Care | -86 | 75 | 90 |
Total ex-logistics OP | 819 | 1,032 | 861 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment Margins & Growth (%) and Revenue by Segment (%)
| Metric (%) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Food OP margin | 5.8 | 5.5 | 4.6 |
Bio OP margin | 6.1 | 8.0 | 5.1 |
Food revenue YoY growth | 1.4 | 0.8 | 1.5 |
Bio revenue YoY growth | -14.8 | 1.8 | -5.4 |
Overseas food share of food revenue | 47.8 | 49.2 | 51.4 |
Segment Revenue
| Item | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Food revenue | 2,924.6 | 2,687.3 | 2,984.0 | ≈3,000 (Kyobo) | 2,844.1 |
Food OP | 128.6 | 90.1 | 168.5 | ≈143 (Kyobo) | 70.9 |
Overseas food revenue | 1,488.1 | 1,368.8 | 1,455.4 | +4.5% YoY (Hana) | +10.1% YoY |
Domestic food revenue | n/v | 1,318.5 | 1,528.6 | +9% YoY processed (Hana) | +1.4% YoY |
Bio revenue | 895.4 | 1,079.8 | 979.4 | ≈1,000 (Kyobo) | 1,350.9 |
Bio OP | 82.5 | 102.4 | 22.0 | 5.5 | 91.0 |
F&C revenue | 542.5 | 555.3 | 569.2 | divested | divested |
Income Statement
| Metric (KRW Bn, consolidated) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue | 26,289.2 | 30,079.5 | 29,023.5 | 29,359.1 | 27,342.6 |
Operating income | 1,524.4 | 1,664.7 | 1,291.6 | 1,553.0 | 1,233.6 |
Net income (incl. minorities) | 892.4 | 802.7 | 559.5 | 361.8 | -417.0 |
Income Statement — Revenue
| Metric (KRW Bn, ex-logistics) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue | 15,744.4 | 18,779.4 | 17,890.5 | 17,871.0 | 17,754.9 |
Operating income | 1,178.7 | 1,268.2 | 819.4 | 1,032.3 | 861.2 |
Margin (%)
| Margin (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Consolidated operating margin | 5.80 | 5.53 | 4.45 | 5.29 | 4.51 |
Consolidated net margin | 3.39 | 2.67 | 1.93 | 1.23 | -1.53 |
Ex-logistics operating margin | 7.49 | 6.75 | 4.58 | 5.78 | 4.85 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Source / note |
|---|---|---|---|---|---|---|
Gross profit | n/v | n/v | n/v | n/v | n/v | — |
EBITDA (KRW Bn) | n/v | n/v | 2,834 | 3,095 (orig.) / 2,470 (restated) | 2,251 | Hanwha (Aug 2025); Kiwoom (Apr 2026). Definitions differ |
Pre-tax income (KRW Bn) | n/v | n/v | n/v | 610.5 (orig.) / 573.5 (restated) | 64.9 | Kiwoom |
Attributable net income (KRW Bn) | 612.9 | n/v | 386 | 148 (orig.) / 132.3 (restated) | -571.5 | Hana (2022); Hanwha; Kiwoom |
EPS, basic (KRW) | n/v | n/v | 25,147 | 9,310 (orig.) / 8,074 (restated) | -34,884 | Hanwha; Kiwoom |
DPS, common (KRW) | 5,000 | 5,500 | n/v | n/v | ≈6,000 | Newsis, Feb 2023 (FY2022 = 1,000×3 + 2,500 final, +500 YoY). FY2025 inferred from quarterly KRW 1,500 payments (record dates Aug 2025, Nov 2025, Feb 2026) and an aggregator yield of 3.16% at KRW 189,600 |
Financial Analysis
| Item | Value | Date / source |
|---|---|---|
Total assets | KRW 29.74tn | FY2025 (Wikipedia business-data infobox) |
Total equity | KRW 11.55tn | FY2025 (same) |
Net debt | KRW 9.49tn (FY2023); KRW 10.12tn (FY2024) | Hanwha Securities, Aug 2025 |
Net debt / EBITDA | 3.7x (end-2024) → 4.3x (Sep 2025) | NICE Ratings via Dealsite, Apr 2026 |
EBITDA / sales | 10.9% (end-2024) → 10.2% (Sep 2025) | NICE Ratings via Dealsite |
Debt / equity | 167.8% (TTM) | TipRanks, mid-2026 |
Current ratio | 0.81 (TTM) | TipRanks, mid-2026 |
Book value per share | KRW 447,258 (FY2025E) | Kiwoom, Apr 2026 |
Inventories | Up about KRW 666.7bn (~30%) after forward purchases of soybeans | Half-year report, per MyDailyByte news digest, Sep 2026 |
Cash & equivalents; short/long-term debt split; goodwill & intangibles; working capital | n/v | — |
Financial Analysis (2)
| Item | Status |
|---|---|
Operating cash flow, capex, free cash flow, dividends paid, buybacks (5-year) | n/v. TipRanks TTM ratios (price/FCF 9.2x; price/OCF 1.9x; mid-2026) imply TTM OCF of roughly KRW 1.5tn and FCF of roughly KRW 0.3tn at a KRW 2.9tn market cap. These are derived and approximate |
Dividends paid (FY2022) | KRW 88.1bn in total (quarterly + final) |
Buybacks | No new buyback authorization found; treasury stock 2.37–2.4% |
Committed growth capex | Hungary about KRW 100bn (EUR 75–80m); Sioux Falls more than KRW 700bn (completion 2027); Japan Chiba about KRW 100bn (done) |
Financial Analysis — ROE
| Ratio | Value | Source / date |
|---|---|---|
ROE | 5.6% (FY2023); 2.0% (FY2024); 3.1% (FY2025E, pre-impairment estimate); negative actual FY2025 | Hanwha, Aug 2025 |
ROA, ROIC, interest coverage, asset turnover, cash conversion cycle | n/v | — |
P/B | 0.42x | Butler.works, Oct 2026 |
EV/EBITDA (TTM) | 5.0x | TipRanks, mid-2026 |
Q2 2025 by Quarter
| Quarter (KRW Bn) | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 7,237.2 | 7,439.5 | 5,457.4 | 7,111.1 | 7,362.1 |
Operating income | 353.1 | 346.5 | 204.8 | 238.1 | 257.5 |
Net income | 209.1 | 119.2 | -798.7 | 119.8 | -3.8 |
Revenue by Region
| Region (KRW Bn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Domestic food (Korea) | 5,877 | 5,772 | 5,597 |
Overseas food (all regions) | 5,388 | 5,581 | 5,925 |
Region Overview
| Region | Latest disclosed data | Source |
|---|---|---|
North America | FY2024 revenue KRW 4,713.8bn. Q1 2025 KRW 1,247.0bn; Q2 2025 KRW 1,112.0bn. Q3 2025 +3%; Q1 2026 +3.5% in KRW (about +2% in USD); Q2 2026 +10.1% in KRW (+4% in USD). The US accounted for more than 80% of overseas food sales in 2024 | Dealsite; Korea Times; Hana/StockHub |
Europe | Annual sales exceeded KRW 100bn for the first time in FY2024. Q1 2025 +36%; Q3 2025 +13%; Q1 2026 +17%; Q2 2026 double-digit. Present in 27 European countries by end-Q3 2025 | Dealsite; CJ Newsroom; Hana |
Japan | Q2 2025 +37% (Mi-cho, dumplings). Chiba plant from Sep 2025. Q3 2025 +4%. Q1 2026 −2% (Kyobo) | Dealsite; Kyobo |
China | Q1 2025 +15%+. Q2 2026 +5% on mandu and frozen rice balls | Dealsite; Herald Corp |
Oceania / APAC | Q1 2025 Oceania +25%; Q3 2025 +5%; Q1 2026 APAC +17%. Bibigo ranged in about 80% of stores of major Australian retailers (FY2024) | Dealsite; Hana |
Latin America | Market-entry stage (bibigo pavilion at a Mexico K-expo, late Sep 2026) | MyDailyByte digest |
Point Details
| Point | Price (KRW) | Source |
|---|---|---|
13 Oct 2020 (reference) | 398,000 | Asia Economy |
10 Feb 2025 | 250,000 | Hanwha |
11 Aug 2025 | 250,000 | Hanwha |
11 Nov 2025 | 229,000 | Kiwoom |
31 Mar 2026 | 216,500 | Kiwoom |
6 Aug 2026 | 201,500 | Investing.com |
30 Sep 2026 | 178,900 | MyDailyByte |
Oct 2026 (latest available) | 189,600 | Butler.works |
52-week range (mid-2026) | 172,600 – 254,000 | TipRanks |
Capital Markets Data
| Market cap (KRW Bn) | Feb 2025 | Aug 2025 | Nov 2025 | Mar 2026 | Oct 2026 |
|---|---|---|---|---|---|
CJ CheilJedang | 3,763.5 | 3,763.5 | 3,447.4 | 3,259.2 | 2,854.3 |
Valuation Multiples
| Multiple | CJ CheilJedang | Source |
|---|---|---|
P/E (trailing) | Not meaningful (FY2025 loss) | Butler.works |
Forward P/E | 10.5x | Butler.works, Oct 2026 |
P/E FY2026E (Kiwoom) | 9.7x at KRW 216,500 | Kiwoom, Apr 2026 |
P/B | 0.42x | Butler.works |
EV/EBITDA (TTM) | 5.0x | TipRanks |
EV/Sales | n/v | — |
Peer multiples | n/v. Samyang Foods market cap about KRW 9.6–9.8tn, roughly 3.4x CJ's on about 13% of CJ's ex-logistics revenue | Yuanta, Apr–May 2026 |
Analyst Ratings & Targets
| Broker | Date | Rating | Target (KRW) |
|---|---|---|---|
Consensus (12 brokers) | Oct 2026 | — | 273,333 |
Kiwoom | 1 Apr 2026 | Buy | 310,000 |
DS Investment & Securities | 2 Jul 2026 | Buy | 300,000 |
Shinhan | 10 Jul 2026 | Buy | 280,000 |
Yuanta | 21 Jul 2026 | Buy | 260,000 |
Hana | Aug 2026 | Buy | 370,000 (per StockHub summary; may be stale) |
DPS, common (KRW)
| DPS, common (KRW) | FY2021 | FY2022 | FY2025 |
|---|---|---|---|
Dividend per share | 5,000 | 5,500 | 6,000 |
Analyst Conclusions
Management guidance
Q3 2026: consolidated sales up low double digits YoY; operating margin in the mid-to-high 4% range.
Bio: YoY recovery expected, with possible QoQ dilution from oil prices.
Strategy: premiumization, global expansion and innovation in Foods and Bio.
Portfolio: continued disposal of non-core assets.
Consensus expectations (Kiwoom, Apr 2026)
| Metric (KRW Bn, consolidated) | FY2025A | FY2026E | FY2027E |
|---|---|---|---|
| Revenue | 27,342.6 | 28,503.2 | 29,415.7 |
| Operating profit | 1,233.6 | 1,323.6 | 1,491.2 |
| Net income | -417.0 | 601.7 | 736.3 |
H1 2026 actual OP was KRW 495.7bn (−17.9% YoY). This implies a heavy 2H weighting is needed to reach the FY2026E figure; the risk of further downward revisions is material.
Bull case
-
Deep value with a visible catalyst path. The stock trades at 0.42x book. Asset sales (F&C closed; starch and plants pending) and a bio upcycle could lift ROE from negative toward the 5–6% levels of FY2023.
-
Bio has troughed. Bio OP recovered from KRW 5.5bn (Q1 2026) to KRW 91bn (Q2 2026) on revenue +20.8%. Multiple brokers expect 2H normalization, helped by grain and oil-driven pricing.
-
The global food engine is intact and gaining capacity. Overseas food is now more than 50% of food sales. Europe and APAC are growing at double digits, and Hungary (2026) and Sioux Falls (2027) add localized capacity in under-penetrated markets.
Bear case
-
Structural margin erosion in staples. Two record antitrust fines, price-reset orders and political scrutiny cap pricing in sugar, flour and starch. Domestic food is shrinking.
-
Chinese competition makes bio a lower-quality earnings stream. FY2025 bio OP fell 36.7%, and tryptophan and specialty premiums are being competed away. The failed KRW 6tn sale suggests the market values the asset below management's view.
-
Balance-sheet and governance overhang. Net debt/EBITDA was 4.3x with NICE triggers in sight; impairments drove a FY2025 net loss; and minority holders face controlling-shareholder priorities and a logistics stake that dilutes the investment case.
Key catalysts and monitorables (next 12 months)
-
Q3 2026 results (about 8–11 Nov 2026): delivery against the low-double-digit sales and mid-to-high 4% margin guidance.
-
First production at the Hungary plant and early European margin data.
-
Outcome of the starch-sweetener and plant sale-leaseback processes, and any further divestments (e.g., Selecta, red bio).
-
The KFTC starch-syrup sanction and any criminal proceedings.
-
NICE and other domestic rating reviews (EBITDA/sales and net debt/EBITDA).
-
Amino acid price trends, especially lysine and tryptophan, and Chinese capacity additions.
-
First restated segment history under the three-division structure.
-
Sioux Falls construction progress toward 2027 commissioning.
Concluding analyst verdict
CJ CheilJedang enters late 2026 as a company whose franchise value and financial performance have diverged sharply. On the franchise side, the evidence is unambiguous. It owns the most successful global Korean-food brand, bibigo, with leadership in the world's largest consumer market (42% of US B2C dumplings). Overseas food has become the majority of its food revenue, and it is investing in localized capacity in Europe and the US Midwest. Its fermentation technology remains globally relevant, as shown by its ability to license strain IP into China itself.
The financial record tells a different story:
-
Consolidated operating profit has fallen from KRW 1.66tn (FY2022) to KRW 1.23tn (FY2025).
-
Net income has fallen from KRW 892bn (FY2021) to a KRW 417bn loss.
-
Leverage has crept toward rating triggers.
-
Two consecutive record antitrust fines have damaged the legitimacy of its domestic staples business.
The July 2026 three-division reorganization is the right diagnosis. It concentrates capital on Lifestyle Food, ring-fences high-value Technology Materials, and puts commodity Core Materials on a cash and synergy mandate with explicit permission to exit marginal units. The question is execution: the 2025 failures to sell the bio business and Selecta show how hard that is.
At about 0.4x book and roughly 10x forward earnings, the market is pricing persistent value destruction. Even modest progress could re-rate the shares: a sustained bio recovery, a completed starch sale and a clean Hungary ramp-up. The 2026 interim numbers (H1 OP −17.9%) do not yet show that progress. On balance the shares screen as deep value with elevated execution and regulatory risk. The risk/reward improves materially once two conditions are met:
-
Q3/Q4 2026 confirm bio normalization.
-
Divestment proceeds visibly reduce net debt below about 4x EBITDA.
Until then, the investment case rests more on asset value than on earnings momentum.
Source notes
Primary and near-primary sources used:
-
CJ CheilJedang IR and press releases (cj.co.kr; CJ Newsroom).
-
DART preliminary results (via StockHub summaries).
-
Company sustainability reports.
Press and research sources used:
-
Korean and international press: Korea Herald, Korea JoongAng Daily, KED Global, Korea Times, Dealsite, Edaily, Herald Corp, Asia Economy, Digital Today, Nocut News, Financial News.
-
Broker research excerpts: Kiwoom, Hanwha, Hana, IBK, iM, Yuanta, DS, Shinhan, Kyobo.
-
Data aggregators (TipRanks, Simply Wall St, Butler.works, Investing.com, TheVC, Quartr) are used only where primary data were unavailable, and are flagged.
Figures should be reconciled to the FY2025 audited business report and the Q2 2026 half-year report on DART before external use.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Background | Source |
|---|---|---|---|---|
Sohn Kyung-shik | Chairman and Representative Director | Long-standing (also CJ Group Chairman) | n/v this cycle | Corporate registry summary |
Yoon Seok-hwan | CEO and Representative Director; concurrently head of Technology Materials | CEO since Oct 2025 | Formerly CEO of the Bio business unit; previously led South American bio operations, global bio marketing and the biotech research centre | Korea JoongAng Daily; Simply Wall St |
Gregory Yep | Head, Lifestyle Food Division | Food division head since 2025 | More than 30 years in R&D and business innovation at global food and nutrition companies | Herald Corp, Jul 2026 |
Kim Chan-ho | Head, Strategic Support Division; concurrently head of Core Materials | Since 2026 reorganization | Former CEO of CJ Foodville | KED Global, Feb 2024; Edaily, Jul 2026 |
Kyoung-suk Kang | Head, Finance Strategy Office | n/v | n/v | Simply Wall St |
Shin Young-soo | CEO, CJ Logistics (subsidiary) | Since Feb 2024 | Launched the O-NE delivery brand | KED Global |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Dec 2020 | Choi Eun-seok CEO; Kang Sin-ho moves to CJ Logistics | Group reshuffle |
Mar 2022 | Pak Min-sok (ex-Mondelez global chief strategist) hired as Chief Growth Officer; later CEO of CJ Foods | Growth/GSP agenda |
Feb 2024 | Kang Sin-ho returns as CEO and Vice Chairman | After FY2023 net profit fell nearly a third |
Oct 2025 | Yoon Seok-hwan replaces Kang (health reasons) | CEO appointments made ahead of the regular reshuffle |
1 Jul 2026 | Three-division leadership: Yep, Yoon (concurrent), Kim (concurrent) | Portfolio restructuring |
Major Shareholders
| Holder | Stake | Date / source |
|---|---|---|
CJ Corp. and related parties | 45.5% | Kiwoom, Apr 2026 |
National Pension Service | 10.0% (down from 12.5% in Feb 2025) | Hanwha, Aug 2025 / Feb 2025 |
Treasury stock | 2.37–2.4% | Butler.works; Hanwha |
Foreign investors (aggregate) | 15.2% (Mar 2026), down from 22.6% (Feb 2025) | Kiwoom; Hanwha |
Top 10 institutional holders (individual) | n/v | — |
Insider ownership (management) | n/v; negligible outside the CJ family / CJ Corp. block | — |
Competitive Landscape
Competitors by Segment
| Segment | Named competitors | Notes |
|---|---|---|
Korean processed food | Daesang (Chung Jung One), Ottogi, Nongshim, Samyang Foods, Dongwon F&B, Pulmuone, Lotte Wellfood | CJ is the largest by revenue |
Korean sugar | Samyang Corp., Daehan Sugar (TS) | Three-player oligopoly fined in 2026 |
Korean flour | Daehan Flour Mills, Sajo DongA One, Samyang Corp., Daesun, Samhwa, Hantop | Top 3 (Daehan, Sajo DongA One, CJ) hold more than 70% of a KRW 1.3tn market |
Korean starch sweeteners | Daesang, Sajo CPK, Samyang | Four firms hold more than 90%; CJ ranks 4th with a low-10% share |
US Asian frozen food / dumplings | Ajinomoto Foods North America (Ling Ling), private label, other Asian-food brands | bibigo holds 42% of US B2C dumplings and leads the No. 2 brand by more than 3x (Dealsite, Feb 2025) |
US frozen pizza | Nestlé (DiGiorno), Conagra, private label | Red Baron/Tony's compete in mainstream frozen pizza |
K-food exports (noodles) | Samyang Foods (Buldak), Nongshim (Shin Ramyun) | Faster-growing, higher-margin K-food exporters |
Feed amino acids | Meihua, Fufeng, Eppen (China), Ajinomoto, ADM, Evonik (methionine), Novus | Chinese low-cost capacity is the structural threat |
Nucleotides / flavour | Ajinomoto, Chinese producers | Price competition intensified in 2025 |
Peer Comparison FY2025
| Metric | CJ CheilJedang (ex-logistics, FY2025) | Ajinomoto (FY to Mar-2026) | Samyang Foods (FY2025) | Ottogi (FY2025) |
|---|---|---|---|---|
Revenue | KRW 17.75tn | JPY 1.58tn | about KRW 2.3tn | about KRW 3.6tn |
Revenue growth | −0.6% | +3.5% | n/v (OP +52% vs FY2024) | n/v |
Operating profit | KRW 861bn | Business profit n/v for FY to Mar-2026; FY to Mar-2025: JPY 159.3bn | KRW 524bn | about KRW 177bn |
Operating margin | 4.9% | about 10.4% (FY to Mar-2025, business profit basis) | about 22.8% | about 4.9% |
Net income | −KRW 417bn (consolidated) | JPY 134.7bn | n/v | n/v |
R&D intensity | about 1.2% (FY2024) | n/v | KRW 7.9bn R&D (FY2024; Hankyung) | n/v |



